Not to be outdone by the MM portfolio, Vidaza sales are at 105% to budget YTD. This has Australia sitting in 2nd place globally (tracking just behind France) in sales since launch of this product.
While Vidaza sales per selling day seem to be slowing, it will be interesting the witness the impact of the Vidaza Injection Program as this product becomes more widely available.
Clearly the Sales team is making amazing headway this year as exemplified by the introduction of a new soft target of 1550 calls for 2013 with the team already achieving >1000 calls nationally.... smashing it! What an incredible start to what we all hope will be another record breaking year!